Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name FOXD2-AS1
   Synonyms NA
   Region GRCh38_1:47432133-47434641    Sequence
   Ensembl ENSG00000237424
   RefSeq NR_026878
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colorectal cancer
   ICD-0-3 C19.9  
   Methods qPCR, Western blot etc.
   Sample CRC tissues, cell lines (RKO, HCT15, HCT28, HCT116, and SW480)
   Expression Pattern up-regulated
   Function Description

FOXD2- AS1 expression was significantly increased in CRC tissues as well as in CRC cell lines. down-regulation of FOXD2-AS1 suppressed cell, proliferation, invasion and migration in vitro. FOXD2-AS1 promoted the progression of CRC by regulating EMT and Notch signaling pathway. Thus, targeting FOXD2-AS1 may be an effective strategy for CRC treatment.Although recent advances have been made in diagnostic procedures and therapeutic strategies, the 5-year survival rate for metastatic CRC is only 10-15%3,4.Waltham,MA, USA) Dulbeccoâ??s modified Eagleâ??s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), Sigma-Aldrich.

   Pubmed ID 28925486
   Year 2017
   Title Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
   External Links
   Links for  FOXD2-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  colorectal cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.